A single-center, phase 1/2a clinical trial to evaluate the safety, maximum tolerated dose, and exploratory efficacy of MR-MC-01 treatment in patients with underactive bladder
A single-center, phase 1/2a clinical trial to evaluate the safety, efficacy, and maximum tolerated dose of MR-MC-01 treatment in patients with interstitial cystitis
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis; Open-labelled, Single Center, Phase 1 Study
This study primarily aimed to evaluate the safety of human embryonic stem cell (hESC)-derived mesenchyma stem cells in interstitial cystitis.
100 项与 MR-MC-01 相关的专利(医药)